ΠΡΠΎΡΡΠΎΠΉ Π³ΡΠ°ΡΠΈΠΊ
Π Π°ΡΡΠΈΡΠ΅Π½Π½ΡΠΉ Π³ΡΠ°ΡΠΈΠΊ
ΠΡΠ½ΠΎΠ²Π½ΡΠ΅ ΠΏΠ°ΡΠ°ΠΌΠ΅ΡΡΡ
| 10 Π»Π΅ΡΠ½ΡΡ Π΄ΠΎΡ ΠΎΠ΄Π½ΠΎΡΡΡ | 0 |
| 3 Π»Π΅ΡΠ½ΡΡ Π΄ΠΎΡ ΠΎΠ΄Π½ΠΎΡΡΡ | 0 |
| 5 Π»Π΅ΡΠ½ΡΡ Π΄ΠΎΡ ΠΎΠ΄Π½ΠΎΡΡΡ | 0 |
| ΠΠ°Π»ΡΡΠ° | usd |
| ΠΠ»Π°Π΄Π΅Π»Π΅Ρ | New York Life |
| ΠΠΎΠ΄ΠΎΠ²Π°Ρ Π΄ΠΎΡ ΠΎΠ΄Π½ΠΎΡΡΡ | 21.52 |
| ΠΠ°ΡΠ° ΠΎΡΠ½ΠΎΠ²Π°Π½ΠΈΡ | 2022-02-08 |
| ΠΠΈΠ² Π΄ΠΎΡ ΠΎΠ΄Π½ΠΎΡΡΡ | 2.42 |
| ΠΠ½Π΄Π΅ΠΊΡ | IQ Global Equity R&D Leaders Index - Benchmark TR Net |
| ΠΠΎΠ΄ ISIN | US45409B2557 |
| ΠΠΎΠ»ΠΈΡΠ΅ΡΡΠ²ΠΎ ΠΊΠΎΠΌΠΏΠ°Π½ΠΈΠΉ | 198 |
| ΠΠΎΠΌΠΈΡΡΠΈΡ | 0.18 |
| ΠΠΎΠ»Π½ΠΎΠ΅ Π½Π°ΠΈΠΌΠ΅Π½ΠΎΠ²Π°Π½ΠΈΠ΅ | NYLI Global Equity R&D Leaders ETF |
| Π Π΅Π³ΠΈΠΎΠ½ | Global |
| Π‘Π°ΠΉΡ | cΡΡΠ»ΠΊΠ° |
| Π‘ΡΠ΅Π΄Π½ΠΈΠΉ P/BV | 1.91 |
| Π‘ΡΠ΅Π΄Π½ΠΈΠΉ P/E | 14.77 |
| Π‘ΡΠ΅Π΄Π½ΠΈΠΉ P/S | 1.06 |
| Π‘ΡΡΠ°Π½Π° | USA |
| Π‘ΡΡΠ°Π½Π° ISO | US |
| Π’ΠΈΠΏ Π°ΠΊΡΠΈΠ²Π° | Equity |
| ΠΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ Π·Π° Π΄Π΅Π½Ρ | +0.1126% (37.315) |
| ΠΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ Π·Π° Π½Π΅Π΄Π΅Π»Ρ | +0.4599% (37.186) |
| ΠΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ Π·Π° ΠΌΠ΅ΡΡΡ | +2.99% (36.272) |
| ΠΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ Π·Π° 3 ΠΌΠ΅ΡΡΡΠ° | +1.51% (36.802) |
| ΠΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ Π·Π° ΠΏΠΎΠ»Π³ΠΎΠ΄Π° | +14.73% (32.56) |
| ΠΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ Π·Π° Π³ΠΎΠ΄ | +21.66% (30.706) |
| ΠΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ Ρ Π½Π°ΡΠ°Π»Π° Π³ΠΎΠ΄Π° | +31.79% (28.346) |
ΠΠΏΠ»Π°ΡΠΈΡΠ΅ ΠΏΠΎΠ΄ΠΏΠΈΡΠΊΡ
ΠΠΎΠ»ΡΡΠ΅ ΡΡΠ½ΠΊΡΠΈΠΎΠ½Π°Π»ΡΠ½ΠΎΡΡΠΈ ΠΈ Π΄Π°Π½Π½ΡΡ Π΄Π»Ρ Π°Π½Π°Π»ΠΈΠ·Π° ΠΊΠΎΠΌΠΏΠ°Π½ΠΈΠΉ ΠΈ ΠΏΠΎΡΡΡΠ΅Π»Ρ Π΄ΠΎΡΡΡΠΏΠ½ΠΎ ΠΏΠΎ ΠΏΠΎΠ΄ΠΏΠΈΡΠΊΠ΅
ΠΠΎΡ ΠΎΠΆΠΈΠ΅ ETF
ΠΡΡΠ³ΠΈΠ΅ ETF ΠΎΡ Π£ΠΏΡΠ°Π²Π»ΡΡΡΠ΅ΠΉ ΠΊΠΎΠΌΠΏΠ°Π½ΠΈΠΈ
ΠΠΏΠΈΡΠ°Π½ΠΈΠ΅ NYLI Global Equity R&D Leaders ETF
The underlying index seeks to provide exposure to innovative companies by investing in the equities of companies that have high research and development ("R&D") spending around the world. The fund invests, under normal circumstances, at least 80% of its net assets, plus the amount of any borrowings for investment purposes, in the investments included in its underlying index. The fund is non-diversified.
ΠΠ° ΠΎΡΠ½ΠΎΠ²Π΅ ΠΈΡΡΠΎΡΠ½ΠΈΠΊΠΎΠ²: porti.ru
